Back
ESC Professional Premium Access

Effects of doxorubicin and ibrutinib on atrial arrhythmogenity: ex-vivo assessment in human myocardium

Session: Arrhythmia mechanisms
Topic: Pathophysiology and Mechanisms
Speaker: Mr Y. Berger (Berlin, DE)
Event: ESC Congress 2022

Congress Presentation

Add to my library

Like

About the speaker

Mr Yannic Wanja Berger

Charité - University Medicine Berlin, Berlin (Germany)
0 follower

6 more presentations in this session

The ideal environment for the development of postcardiac surgery atrial fibrillation: evidence for endothelial activation and poor cell-cell interaction.

Speaker: Doctor R. Lopez-Galvez (Murcia, ES)

Access
Abstract
Slides
Like
Thumbnail

Pulmonary vein anatomical variants and incidence of atrial fibrillation

Speaker: Doctor R. Gallen (Dublin, IE)

Access
Abstract
Slides
Like
Thumbnail

Identifying proteomic profiles as indicators of disease severity in arrhythmogenic cardiomyopathy

Speaker: Doctor D. Akdis (Zurich, CH)

Access
Abstract
Slides
Like
Thumbnail

Immune status comparison in patients with atrial fibrillation or flutter on the base of arterial hypertension

Speaker: Doctor O. Stasyshena (Kiev, UA)

Access
Abstract
Slides
Like
Thumbnail

"Concealed cardiomyopathy" is an important cause of autopsy-inconclusive sudden cardiac death and diagnosis impacts care of surviving relatives

Speaker: Doctor J. Isbister (Sydney, AU)

Access
Abstract
Slides
Like
Thumbnail

Access the full session

Arrhythmia mechanisms

Speakers: Mr Y. Berger, Doctor R. Lopez-Galvez, Doctor R. Gallen, Doctor D. Akdis, Doctor O. Stasyshena...
Access
Like
Thumbnail

About the event

Image

ESC Congress 2022

26 August - 29 August 2022

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

logo Bristol Myers Squibb Explore sponsored resources
logo Novo Nordisk Explore sponsored resources